Rock Springs Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Rock Springs Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,660,822	Closed	-$100M	–	165
2021 Q1	$100M	Buy	2,660,822 +1,939,189	+269%	+$73M	2.19%	6
2020 Q4	$12.3M	Buy	721,633 +450,048	+166%	+$7.66M	0.26%	103
2020 Q3	$1.28M	Sell	271,585 -135,144	-33%	-$635K	0.03%	143
2020 Q2	$2.48M	Buy	406,729 +6,729	+2%	+$41K	0.07%	135
2020 Q1	$908K	Hold	400,000	–	–	0.04%	128
2019 Q4	$1.84M	Sell	400,000 -375,000	-48%	-$1.72M	0.06%	118
2019 Q3	$3M	Buy	775,000 +248,900	+47%	+$964K	0.12%	122
2019 Q2	$3.17M	Buy	526,100 +21,100	+4%	+$127K	0.11%	120
2019 Q1	$6.77M	Hold	505,000	–	–	0.26%	95
2018 Q4	$4.7M	Sell	505,000 -93,000	-16%	-$865K	0.22%	98
2018 Q3	$8.32M	Buy	598,000 +5,000	+0.8%	+$69.6K	0.3%	94
2018 Q2	$9.38M	Buy	593,000 +7,500	+1%	+$119K	0.36%	88
2018 Q1	$10.1M	Buy	585,500 +160,500	+38%	+$2.76M	0.43%	79
2017 Q4	$9.32M	Buy	425,000 +207,300	+95%	+$4.54M	0.42%	77
2017 Q3	$8.91M	Buy	217,700 +20,700	+11%	+$847K	0.41%	77
2017 Q2	$5.93M	Buy	197,000 +32,000	+19%	+$964K	0.3%	89
2017 Q1	$5.97M	Buy	165,000 +1,000	+0.6%	+$36.2K	0.34%	80
2016 Q4	$8.22M	Sell	164,000 -2,250	-1%	-$113K	0.55%	56
2016 Q3	$8.73M	Buy	166,250 +13,250	+9%	+$695K	0.55%	54
2016 Q2	$6.33M	Buy	153,000 +8,500	+6%	+$352K	0.47%	67
2016 Q1	$5.87M	Buy	144,500 +9,500	+7%	+$386K	0.49%	69
2015 Q4	$5.6M	Buy	135,000 +15,000	+13%	+$623K	0.42%	79
2015 Q3	$1.85M	Hold	120,000	–	–	0.15%	111
2015 Q2	$2.98M	Sell	120,000 -16,000	-12%	-$397K	0.22%	104
2015 Q1	$3.11M	Buy	136,000 +16,000	+13%	+$366K	0.29%	87
2014 Q4	$3.24M	Buy	120,000 +5,000	+4%	+$135K	0.38%	77
2014 Q3	$1.35M	Sell	115,000 -10,000	-8%	-$117K	0.21%	79
2014 Q2	$1.94M	Sell	125,000 -50,000	-29%	-$778K	0.35%	71
2014 Q1	$3.44M	Buy	+175,000	New	+$3.44M	0.79%	39